ApprovalTrail

Approval · Notice of Compliance 24405 · 2020

SYNALAR: Notice of Compliance 24405

Issued October 8, 2020

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
24405
Date
October 8, 2020
Company
Bausch Health, Canada Inc.Laval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Change in product ownership

Products in this notice

BrandDINStatus today
SYNALAR02162512Dormant
SYNALAR02162504Cancelled Post Market

Medicinal ingredients